Kumar S, Singh S K, Kole P L, Elmarakby S, Sikka H C
Laboratory of Environmental Toxicology and Chemistry, State University of New York College, Buffalo 14222.
Carcinogenesis. 1995 Mar;16(3):525-30. doi: 10.1093/carcin/16.3.525.
The carcinogen dibenz[a,h]acridine (DB[a,h]ACR is metabolized predominantly to trans-3,4-dihydroxy-3,4-dihydro-dibenz[a,h]acridine (DB[a,h]ACR-3,4-diol) and the proximate carcinogen trans-10,11-dihydroxy-10,11-dihydrodibenz[a,h]acridine (DB[a,h]ACR-10,11-diol) [Steward et al. (1987) Carcinogenesis, 8, 1043-1050]. In the present investigation, the stereoselectivity of rat liver enzymes in metabolism of DB[a,h]ACR to its 3,4-diol and 10,11-diol and of DB[a,h]ACR-10,11-diol enantiomers to their bay-region diol epoxides has been examined with liver microsomes from control and 3-methylcholanthrene-treated rats. Both microsomal preparations produced the major metabolites DB[a,h]ACR-3,4-diol and DB[a,h]ACR-10,11-diol containing predominantly R,R-enantiomers with 38-54% optical purity. Metabolism of (-)-(10R,11R)- and (+)-(10S,11S)-enantiomers of DB[a,h]ACR-10,11-diol by liver microsomes from control rats produced predominantly bay-region diol epoxides (46-59% of total metabolites), whereas very little bay-region diol epoxides (14-17% of total metabolites) were produced by liver microsomes from 3-methylcholanthrene-treated rats. The bay-region diol epoxides produced in these studies consisted of predominantly DB[a,h]ACR-10,11-trans-diol epoxide diastereomer in which the benzylic hydroxyl group and epoxide oxygen are trans. However, (-)-DB[a,h]ACR-10R,11R-diol, a major metabolite of DB[a,h]ACR, was metabolized by liver microsomes from 3-methylcholanthrene-treated rats to (+)-[8R,9S,10S,11R]-DB[a,h]ACR-10,11-trans-diol epoxide, a diastereomer which displayed high mutagenic activity in V79 cells, in an amount which was 6.5-fold greater than that of the corresponding cis-diol epoxide diastereomer. The relative amounts of trans-diol epoxide versus cis-diol epoxide in the mixture of bay-region diol epoxides produced from DB[a,h]ACR-10R,11R-diol and DB[a,h]ACR-10S,11R-diol with liver microsomes from control rats and from DB[a,h]ACR-10S,11S-diol with liver microsomes from 3-methylcholanthrene-treated rats were 1.7, 2.1 and 2.3 respectively.
致癌物二苯并[a,h]吖啶(DB[a,h]ACR)主要代谢为反式-3,4-二羟基-3,4-二氢二苯并[a,h]吖啶(DB[a,h]ACR-3,4-二醇)和近致癌物反式-10,11-二羟基-10,11-二氢二苯并[a,h]吖啶(DB[a,h]ACR-10,11-二醇)[Steward等人(1987年),《癌变》,8,1043 - 1050]。在本研究中,用对照大鼠和经3-甲基胆蒽处理的大鼠的肝微粒体,研究了大鼠肝脏酶将DB[a,h]ACR代谢为其3,4-二醇和10,11-二醇以及将DB[a,h]ACR-10,11-二醇对映体代谢为其湾区二醇环氧化物的立体选择性。两种微粒体制剂都产生了主要代谢产物DB[a,h]ACR-3,4-二醇和DB[a,h]ACR-10,11-二醇,它们主要含有光学纯度为38 - 54%的R,R-对映体。对照大鼠的肝微粒体对DB[a,h]ACR-10,11-二醇的(-)-(10R,11R)-和(+)-(10S,11S)-对映体的代谢主要产生湾区二醇环氧化物(占总代谢产物的46 - 59%),而经3-甲基胆蒽处理的大鼠的肝微粒体产生的湾区二醇环氧化物很少(占总代谢产物的14 - 17%)。这些研究中产生的湾区二醇环氧化物主要由DB[a,h]ACR-10,11-反式二醇环氧化物非对映体组成,其中苄基羟基和环氧基氧是反式的。然而,DB[a,h]ACR的主要代谢产物(-)-DB[a,h]ACR-10R,11R-二醇被经3-甲基胆蒽处理的大鼠的肝微粒体代谢为(+)-[8R,9S,10S,11R]-DB[a,h]ACR-10,11-反式二醇环氧化物,该非对映体在V79细胞中显示出高诱变活性,其生成量比相应的顺式二醇环氧化物非对映体大6.5倍。用对照大鼠的肝微粒体由DB[a,h]ACR-10R,11R-二醇和DB[a,h]ACR-10S,11R-二醇产生的以及用经3-甲基胆蒽处理的大鼠的肝微粒体由DB[a,h]ACR-10S,11S-二醇产生的湾区二醇环氧化物混合物中,反式二醇环氧化物与顺式二醇环氧化物的相对量分别为1.7、2.1和2.3。